ArticleCancers2022

Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.

Pankita H Pandya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.